Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription Articles published in Pediatr Infect Dis J Retrieve available abstracts of 38 articles: HTML format

Single Articles

June 2025
1. GHAMBI-ZULU L, Nyirenda J, Chawinga C, Mtolongo R, et al
   Respiratory Microbial Codetection and Clinical Profiles of Infants Living With HIV Hospitalized With Severe Pneumonia in Malawi.
   Pediatr Infect Dis J. 2025 Jun 20. doi: 10.1097/INF.0000000000004907.
   PubMed     Abstract available
   
   
   
2. DOWLING S, Hackett S, Simao L, Hast M, et al
   Accelerating Uptake of Optimal Antiretrovirals for Children and Adolescents Living With HIV in Nigeria, Tanzania, Uganda and Zambia Through Data-driven Quality Improvement Interventions.
   Pediatr Infect Dis J. 2025 Jun 6. doi: 10.1097/INF.0000000000004893.
   PubMed     Abstract available
   
   
   May 2025
3. RABIE H, Yin DE, Ward S, Rani Y, et al
   Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results.
   Pediatr Infect Dis J. 2025 May 23. doi: 10.1097/INF.0000000000004859.
   PubMed     Abstract available
   
   
   
4. WACHARACHAISURAPOL N, Rungsapphaiboon A, Anugulruengkitt S, Sirikutt P, et al
   Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
   Pediatr Infect Dis J. 2025;44:428-430.
   PubMed     Abstract available
   
   
   April 2025
5. LOMBAARD J, Moolasart V, Lutaakome J, Van Solingen-Ristea R, et al
   Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naive Children With HIV >/=6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study.
   Pediatr Infect Dis J. 2025 Apr 18. doi: 10.1097/INF.0000000000004828.
   PubMed     Abstract available
   
   
   
6. PRABHUDAS-STRYCKER K, Waugh M, Bates B, Weaver B, et al
   Postpandemic Trends and Missed Opportunities in Prevention and Diagnosis of Pediatric HIV.
   Pediatr Infect Dis J. 2025 Apr 15. doi: 10.1097/INF.0000000000004822.
   PubMed     Abstract available
   
   
   
7. ANTWI S, Enimil A, Yang H, Martyn-Dickens C, et al
   Pharmacokinetics of Tenofovir Diphosphate, Lamivudine Triphosphate and Emtricitabine Triphosphate in Adolescents With HIV Infection With and Without Tuberculosis Coinfection.
   Pediatr Infect Dis J. 2025 Apr 10. doi: 10.1097/INF.0000000000004831.
   PubMed     Abstract available
   
   
   
8. PATTEN G, Malateste K, Bolton Moore C, Sipambo N, et al
   Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIV.
   Pediatr Infect Dis J. 2025 Apr 4. doi: 10.1097/INF.0000000000004819.
   PubMed     Abstract available
   
   
   
9. FOUGERE Y, Brophy J, Hawkes MT, Lee T, et al
   Clinical and Immunologic Impact of CMV Coinfection Among Children Living With HIV in Canada.
   Pediatr Infect Dis J. 2025 Apr 3. doi: 10.1097/INF.0000000000004811.
   PubMed     Abstract available
   
   
   
10. JACOBS TG, Ooms GI, Mantel-Teeuwisse AK, Suleman F, et al
    Commentary: Pediatric HIV Treatment: Nurturing Access Through Health Facility Availability and Stock-out Monitoring.
    Pediatr Infect Dis J. 2025 Apr 3. doi: 10.1097/INF.0000000000004814.
    PubMed    
    
    
    March 2025
11. TORRE P 3RD, Elliott H, Shinn J, Mangino AA, et al
    Central Auditory Processing in Children is Affected by Perinatal HIV Exposure.
    Pediatr Infect Dis J. 2025 Mar 12. doi: 10.1097/INF.0000000000004796.
    PubMed     Abstract available
    
    
    February 2025
12. GILL MM, Khumalo PN, Hoffman HJ, Chouraya C, et al
    Birth Defects and Adverse Pregnancy Outcomes in Hospital-based Birth Surveillance in Eswatini.
    Pediatr Infect Dis J. 2025 Feb 3. doi: 10.1097/INF.0000000000004745.
    PubMed     Abstract available
    
    
    
13. BOURNE J, Sawry S, Le Roux J, Fairlie L, et al
    Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    
14. DANIEL O, Nalwoga J, Kyohere M, Nsimire Sendagala J, et al
    Impact of HIV Status on Group B Streptococcus Colonization and Antibody Responses in Serum and Vaginal Mucosa.
    Pediatr Infect Dis J. 2025;44.
    PubMed     Abstract available
    
    
    January 2025
15. PEREIRA MO, Ribeiro M, Patraquim C, Alves MC, et al
    Advanced HIV Disease in Children: Clinical Practice Cases in Portugal.
    Pediatr Infect Dis J. 2025 Jan 30. doi: 10.1097/INF.0000000000004750.
    PubMed    
    
    
    
16. ODERO L, Chafetz A, Gikura M, Goldstein D, et al
    The Impact of Aging on Measurement of Continuity of Treatment Among Children Living With HIV in the PEPFAR Supported Program in Kenya.
    Pediatr Infect Dis J. 2025 Jan 30. doi: 10.1097/INF.0000000000004702.
    PubMed     Abstract available
    
    
    
17. WILLIAMS T, Unternaher J, Koay WLA, Anderson L, et al
    Efficacy, Safety and Retention in Care Among Adolescents and Youth With HIV on Long-Acting Injectable Cabotegravir/Rilpivirine Treatment: Real-World Observational Cohort Outcomes.
    Pediatr Infect Dis J. 2025 Jan 24. doi: 10.1097/INF.0000000000004742.
    PubMed     Abstract available
    
    
    
18. MAGDALENO AM, Friedrich L, Ramos MA, Corso AL, et al
    Prevalence of Anti-HIV Antibodies at 12 Months of Age in Infants Exposed to HIV.
    Pediatr Infect Dis J. 2025 Jan 17. doi: 10.1097/INF.0000000000004732.
    PubMed     Abstract available
    
    
    
19. WACHARACHAISURAPOL N, Rungsapphaiboon A, Anugulruengkitt S, Sirikutt P, et al
    Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
    Pediatr Infect Dis J. 2025 Jan 10. doi: 10.1097/INF.0000000000004683.
    PubMed     Abstract available
    
    
    
20. SUNDAR KG, Yang LZ, Cambou MC, Varella IRS, et al
    Prompt Initiation of Maternal Antiretroviral Therapy After HIV Seroconversion in Pregnancy Effectively Prevents Vertical Transmission and Other Adverse Infant Outcomes.
    Pediatr Infect Dis J. 2025;44:40-43.
    PubMed     Abstract available
    
    
    December 2024
21. ALONSO YANEZ S, Juarez Lorenzana JW, Prieto Tato L, Guillen Martin S, et al
    Impact of the COVID-19 Pandemic on the Follow-up of Children and Adolescents With HIV Infection in Guatemala.
    Pediatr Infect Dis J. 2024 Dec 23. doi: 10.1097/INF.0000000000004674.
    PubMed     Abstract available
    
    
    
22. BARDAJI A, Dobano C, Alonso S, Vala A, et al
    Effect of HIV and Malaria in Pregnancy on Pertussis-specific Antibodies and Transplacental Antibody Transfer: A Secondary Analysis of a Prospective Cohort Study in Mozambican Pregnant Women and Their Infants.
    Pediatr Infect Dis J. 2024 Dec 4. doi: 10.1097/INF.0000000000004647.
    PubMed     Abstract available
    
    
    November 2024
23. MUNOZ FM, Beigi R, Posavad CM, Kelly C, et al
    Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
    Pediatr Infect Dis J. 2024;43:1065-1073.
    PubMed     Abstract available
    
    
    October 2024
24. DUBOIS MM, Jao J, Sun S, Legbedze J, et al
    Infectious Morbidity and All-cause Mortality of Infants HIV-exposed Uninfected Compared to Infants HIV-unexposed Uninfected in Botswana.
    Pediatr Infect Dis J. 2024 Oct 31. doi: 10.1097/INF.0000000000004603.
    PubMed     Abstract available
    
    
    
25. MRUBATA KL, Bailie V, Solomon F, Izu A, et al
    Impact of Respiratory Syncytial Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection on Clinical Severity and Outcomes Among Children Hospitalized With Lower Respiratory Tract Infections in Soweto, South Africa.
    Pediatr Infect Dis J. 2024 Oct 2. doi: 10.1097/INF.0000000000004560.
    PubMed     Abstract available
    
    
    August 2024
26. CHAPMAN KS, Luhanga M, Mtonga G, Agathis N, et al
    Mortality Among Children Under Five Years of Age Living With HIV on Antiretroviral Treatment From HIV Case Surveillance Data, Malawi, 2022.
    Pediatr Infect Dis J. 2024 Aug 5. doi: 10.1097/INF.0000000000004491.
    PubMed     Abstract available
    
    
    
27. RUNGSAPPHAIBOON A, Wacharachaisurapol N, Anugulruengkitt S, Sirikutt P, et al
    Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
    Pediatr Infect Dis J. 2024;43:789-794.
    PubMed     Abstract available
    
    
    July 2024
28. DE BEER ST, Davies MA, Phelanyane F, Jones HE, et al
    The Retrospective Implementation of Standardized In Utero HIV Exposure Definitions Using Routinely Collected Public Sector Data Across the Western Cape Province, South Africa.
    Pediatr Infect Dis J. 2024 Jul 24. doi: 10.1097/INF.0000000000004486.
    PubMed     Abstract available
    
    
    
29. ANDERSON K, van Zyl G, Hsiao NY, Claassen M, et al
    HIV Drug Resistance in Newly Diagnosed Young Children in the Western Cape, South Africa.
    Pediatr Infect Dis J. 2024 Jul 23. doi: 10.1097/INF.0000000000004482.
    PubMed     Abstract available
    
    
    
30. KAKANDE E, Ssekyanzi B, Abbott R, Ariho W, et al
    Prevalence and Predictors of Tuberculosis Infection in Children and Adolescents in Rural Uganda: A Cross-sectional Study.
    Pediatr Infect Dis J. 2024 Jul 15. doi: 10.1097/INF.0000000000004475.
    PubMed     Abstract available
    
    
    
31. MADHI SA, Ceballos A, Cousin L, Domachowske JB, et al
    Population Attributable Risk of Wheeze in 2-<6-Year-old Children, Following a Respiratory Syncytial Virus Lower Respiratory Tract Infection in The First 2 Years of Life.
    Pediatr Infect Dis J. 2024 Jul 1. doi: 10.1097/INF.0000000000004447.
    PubMed     Abstract available
    
    
    June 2024
32. HOMANS J, Blieden C
    Maternal Syphilis Leading to High Efficiency In Utero Transmission of Antiretroviral Resistant HIV: Intersection of Two Pandemics.
    Pediatr Infect Dis J. 2024 Jun 12. doi: 10.1097/INF.0000000000004414.
    PubMed     Abstract available
    
    
    May 2024
33. RUNGSAPPHAIBOON A, Wacharachaisurapol N, Anugulruengkitt S, Sirikutt P, et al
    Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
    Pediatr Infect Dis J. 2024 May 20. doi: 10.1097/INF.0000000000004366.
    PubMed     Abstract available
    
    
    
34. COMBS M, Johnson A, Abbotsford J, Bowen AC, et al
    Evaluation of Pediatric HIV Postexposure Prophylaxis Guideline Following Child Sexual Assault in Western Australia.
    Pediatr Infect Dis J. 2024 May 7. doi: 10.1097/INF.0000000000004370.
    PubMed     Abstract available
    
    
    March 2024
35. GREYBE L, Barnabas S, Cotton M, Rose P, et al
    Cardiometabolic Risk Profiles of Adolescents Living With Perinatally Acquired HIV in South Africa.
    Pediatr Infect Dis J. 2024 Mar 26. doi: 10.1097/INF.0000000000004340.
    PubMed     Abstract available
    
    
    February 2024
36. NYAKATO P, Boulle A, Wood R, Eley B, et al
    Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial Records.
    Pediatr Infect Dis J. 2024 Feb 21. doi: 10.1097/INF.0000000000004281.
    PubMed     Abstract available
    
    
    
37. KENNEALLY AM, Bates BN
    Accidental Raltegravir Overdose in a Neonate: Case Report and Review of Literature.
    Pediatr Infect Dis J. 2024 Feb 6. doi: 10.1097/INF.0000000000004273.
    PubMed    
    
    
    
38. MALIK F, Crichton S, Plotnikova Y, Latysheva I, et al
    Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe.
    Pediatr Infect Dis J. 2024 Feb 2. doi: 10.1097/INF.0000000000004271.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.